BioCentury
ARTICLE | Clinical News

ONCOS-102: Phase Ib/II started

July 18, 2016 7:00 AM UTC

Targovax began an open-label, European Phase Ib/II trial to evaluate intratumoral ONCOS-102 plus pemetrexed and cisplatin in about 30 patients. This half, Targovax plans to begin 3 additional combinat...